mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.5 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
PHA-665752 |
GDSC1000 |
pan-cancer |
AAC |
0.036 |
0.5 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.5 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |